QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals;
QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee...
top of page
- Nov 9
Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies
Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk...
- Nov 7
NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced it has submitted a 510(k) premarket notification to the ...
- Oct 3
NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced approval of the Monarch eTNS System by Singapore’s Health...
- Aug 22
Bredis Healthcare Awarded South Korean Government Grant
Bredis Healthcare Awarded South Korean Government Grant for Advancing Early Diagnosis of Alzheimer's Disease Bredis Healthcare secures...
- Aug 15
Lactiga Receives FDA 'Rare Pediatric Disease' Designation
Lactiga Receives FDA 'Rare Pediatric Disease' Designation for Groundbreaking Mucosal Immunoglobulin Therapy for Common Variable...
- Aug 11
Austrianova and ProAgni sign license and manufacturing agreement
Austrianova and ProAgni sign license and manufacturing agreement to reduce methane and improve production in cattle Austrianova’s room...
- Jul 12
NeuroSigma Establishes Singapore Subsidiary
Enables Strategic Research Partnerships and Platform for Southeast Asia Commercialization LOS ANGELES, July 12, 2023 (GLOBE NEWSWIRE)...
bottom of page